5. May 2023 – Pipeline meetings between regulatory authorities represented in the consortium and pharmaceutical and biotechnology companies are an opportunity to exchange information on new developments and collaborate on new possibilities. The meetings will also help Access regulators plan and prepare for future work-share applications. Information discussed in these meetings will remain confidential.

For more information, see here.